Disclosure Of Interests In Other Entities [Text Block]

GenSight Biologics S.A. - Filing #2810901

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	—	6,529,000 EUR	—	—	22,947,000 EUR	—	—	—	—	—	—
Non-current assets	—	—	—	2,603,000 EUR	—	—	2,994,000 EUR	—	—	—	—	—	—
Current liabilities	—	—	—	25,290,000 EUR	—	—	14,642,000 EUR	—	—	—	—	—	—
Non-current liabilities	—	—	—	14,543,000 EUR	—	—	26,577,000 EUR	—	—	—	—	—	—
Revenue	—	1,267,000 EUR	—	—	—	—	—	—	—	—	2,582,000 EUR	—	—
Profit (loss)	— EUR	26,220,000 EUR	26,220,000 EUR	—	— EUR	— EUR	—	— EUR	— EUR	27,625,000 EUR	27,625,000 EUR	— EUR	—
Comprehensive income	0 EUR	26,111,000 EUR	26,220,000 EUR	—	0 EUR	109,000 EUR	—	124,000 EUR	0 EUR	27,625,000 EUR	27,748,000 EUR	0 EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	2,134,000 EUR	—	—	10,610,000 EUR	—	—	—	—	—	44,288,000 EUR
Tax expense (income)	—	0 EUR	—	—	—	—	—	—	—	—	5,000 EUR	—	—